IRIS Accounts Production v23.1.0.753 05460337 director 1.6.22 31.5.23 31.5.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure054603372022-05-31054603372023-05-31054603372022-06-012023-05-31054603372021-05-31054603372021-06-012022-05-31054603372022-05-3105460337ns15:EnglandWales2022-06-012023-05-3105460337ns14:PoundSterling2022-06-012023-05-3105460337ns10:Director12022-06-012023-05-3105460337ns10:PrivateLimitedCompanyLtd2022-06-012023-05-3105460337ns10:SmallEntities2022-06-012023-05-3105460337ns10:AuditExemptWithAccountantsReport2022-06-012023-05-3105460337ns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3105460337ns10:SmallCompaniesRegimeForAccounts2022-06-012023-05-3105460337ns10:FullAccounts2022-06-012023-05-3105460337ns10:RegisteredOffice2022-06-012023-05-3105460337ns5:CurrentFinancialInstruments2023-05-3105460337ns5:CurrentFinancialInstruments2022-05-3105460337ns5:ShareCapital2023-05-3105460337ns5:ShareCapital2022-05-3105460337ns5:RetainedEarningsAccumulatedLosses2023-05-3105460337ns5:RetainedEarningsAccumulatedLosses2022-05-3105460337ns5:PlantMachinery2022-06-012023-05-3105460337ns5:OwnedAssets2022-06-012023-05-3105460337ns5:OwnedAssets2021-06-012022-05-3105460337ns5:PlantMachinery2022-05-3105460337ns5:PlantMachinery2023-05-3105460337ns5:PlantMachinery2022-05-31
REGISTERED NUMBER: 05460337 (England and Wales)















Report of the Director and

Financial Statements for the Year Ended 31 May 2023

for

Andy Breakell Medical Legal Limited

Andy Breakell Medical Legal Limited (Registered number: 05460337)






Contents of the Financial Statements
for the Year Ended 31 May 2023




Page

Company Information 1

Report of the Director 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 5


Andy Breakell Medical Legal Limited

Company Information
for the Year Ended 31 May 2023







DIRECTOR: Dr A Breakell





REGISTERED OFFICE: 23 Dowhills Road
Blundellsands
Liverpool
L23 8SJ





REGISTERED NUMBER: 05460337 (England and Wales)





ACCOUNTANTS: M P Greaves Limited
Chartered Certified Accountants
74 Marmot Road
Liverpool
Merseyside
L37 6GB

Andy Breakell Medical Legal Limited (Registered number: 05460337)

Report of the Director
for the Year Ended 31 May 2023

The director presents his report with the financial statements of the company for the year ended 31 May 2023.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of medical report writing.

DIRECTOR
Dr A Breakell held office during the whole of the period from 1 June 2022 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Dr A Breakell - Director


23 February 2024

Andy Breakell Medical Legal Limited (Registered number: 05460337)

Income Statement
for the Year Ended 31 May 2023

31.5.23 31.5.22
Notes £    £   

TURNOVER 25,560 14,160

Cost of sales 8,777 5,555
GROSS PROFIT 16,783 8,605

Administrative expenses 9,143 6,184
OPERATING PROFIT 4 7,640 2,421

Interest receivable and similar income 428 121
PROFIT BEFORE TAXATION 8,068 2,542

Tax on profit 1,615 484
PROFIT FOR THE FINANCIAL YEAR 6,453 2,058

Andy Breakell Medical Legal Limited (Registered number: 05460337)

Balance Sheet
31 May 2023

31.5.23 31.5.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 1,438 1,868

CURRENT ASSETS
Cash at bank 30,033 10,923

CREDITORS
Amounts falling due within one year 6 19,661 7,434
NET CURRENT ASSETS 10,372 3,489
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,810

5,357

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 11,710 5,257
SHAREHOLDERS' FUNDS 11,810 5,357

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 23 February 2024 and were signed by:





Dr A Breakell - Director


Andy Breakell Medical Legal Limited (Registered number: 05460337)

Notes to the Financial Statements
for the Year Ended 31 May 2023

1. STATUTORY INFORMATION

Andy Breakell Medical Legal Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. OPERATING PROFIT

The operating profit is stated after charging:

31.5.23 31.5.22
£    £   
Depreciation - owned assets 480 623

Andy Breakell Medical Legal Limited (Registered number: 05460337)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2022 8,351
Additions 50
At 31 May 2023 8,401
DEPRECIATION
At 1 June 2022 6,483
Charge for year 480
At 31 May 2023 6,963
NET BOOK VALUE
At 31 May 2023 1,438
At 31 May 2022 1,868

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.23 31.5.22
£    £   
Taxation and social security 1,615 484
Other creditors 18,046 6,950
19,661 7,434